Enhancement of Docetaxel-Induced Cytotoxicity by Blocking Epidermal Growth Factor Receptor and Cyclooxygenase-2 Pathways in Squamous Cell Carcinoma of the Head and Neck
Choe, Mi Sun, Chen, Zhuo, Klass, Carmen M, Zhang, Xin, Shin, Dong M
Published in Clinical cancer research (15.05.2007)
Published in Clinical cancer research (15.05.2007)
Get full text
Journal Article
Phase II Study of Docetaxel in Combination with Everolimus for Second- or Third-Line Therapy of Advanced Non–Small-Cell Lung Cancer
Ramalingam, Suresh S., Owonikoko, Taofeek K., Behera, Madhusmita, Subramanian, Janakiraman, Saba, Nabil F., Kono, Scott A., Gal, Anthony A., Sica, Gabriel, Harvey, R. Donald, Chen, Zhengjia, Klass, Carmen M., Shin, Dong M., Fu, Haian, Sun, Shi-yong R., Govindan, Ramaswamy, Khuri, Fadlo R.
Published in Journal of thoracic oncology (01.03.2013)
Published in Journal of thoracic oncology (01.03.2013)
Get full text
Journal Article
Sequence dependence of cell growth inhibition by EGFR-tyrosine kinase inhibitor ZD1839, docetaxel, and cisplatin in head and neck cancer
Klass, Carmen M., Choe, Mi Sun, Hurwitz, Selwyn J., Tighiouart, Mourad, Zhang, Xin, Chen, Zhuo (Georgia), Shin, Dong M.
Published in Head & neck (01.10.2009)
Published in Head & neck (01.10.2009)
Get full text
Journal Article
Enhancement of docetaxel-lnduced cytotoxicity by blocking epidermal growth factor receptor and cyclooxygenase-2 pathways in squamous cell carcinoma of the head and neck
MI SUN CHOE, ZHUO CHEN, KLASS, Carmen M, XIN ZHANG, SHIN, Dong M
Published in Clinical cancer research (2007)
Get full text
Published in Clinical cancer research (2007)
Journal Article